ESR1 and breast cancer: Previous studies have demonstrated that PD-L1 expression in breast cancer is positively associated with high TIL levels and with the presence of poor prognostic factors such as high histologic grade, negative ER and PR status, positive HER2 status, and TNBC status [5, 16, 31].